Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 1
2001 1
2002 2
2003 1
2004 1
2006 2
2007 1
2008 2
2009 2
2010 3
2011 8
2012 7
2013 8
2014 11
2015 6
2016 7
2017 6
2018 14
2019 9
2020 12
2021 10
2022 14
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 34375618

107 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders.
Marsh RA, Hebert K, Kim S, Dvorak CC, Aquino VM, Baker KS, Chellapandian D, Dávila Saldaña B, Duncan CN, Eckrich MJ, Georges GE, Olson TS, Pulsipher MA, Shenoy S, Stenger E, Lugt MV, Yu LC, Gennery AR, Eapen M. Marsh RA, et al. J Allergy Clin Immunol. 2022 Mar;149(3):1097-1104.e2. doi: 10.1016/j.jaci.2021.07.031. Epub 2021 Aug 8. J Allergy Clin Immunol. 2022. PMID: 34375618 Free PMC article.
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant.
Ghosh N, Ahmed S, Ahn KW, Khanal M, Litovich C, Aljurf M, Bacher VU, Bredeson C, Epperla N, Farhadfar N, Freytes CO, Ganguly S, Haverkos B, Inwards D, Kamble RT, Lazarus HM, Lekakis L, Murthy HS, Nishihori T, Ramakrishnan P, Rizzieri DA, Yared JA, Kharfan-Dabaja MA, Sureda A, Hamadani M. Ghosh N, et al. JAMA Oncol. 2020 Jul 1;6(7):1011-1018. doi: 10.1001/jamaoncol.2020.1278. JAMA Oncol. 2020. PMID: 32496525 Free PMC article.
Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia.
Dhere V, Edelman S, Waller EK, Langston A, Graiser M, Connolly EC, Switchenko JM, Esiashvili N, Khan MK. Dhere V, et al. Leuk Lymphoma. 2018 Apr;59(4):837-843. doi: 10.1080/10428194.2017.1361027. Epub 2017 Aug 7. Leuk Lymphoma. 2018. PMID: 28782395 Free PMC article.
Fludarabine and exposure-targeted busulfan compares favorably with busulfan/cyclophosphamide-based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicity.
Bartelink IH, van Reij EM, Gerhardt CE, van Maarseveen EM, de Wildt A, Versluys B, Lindemans CA, Bierings MB, Boelens JJ. Bartelink IH, et al. Biol Blood Marrow Transplant. 2014 Mar;20(3):345-53. doi: 10.1016/j.bbmt.2013.11.027. Epub 2013 Dec 4. Biol Blood Marrow Transplant. 2014. PMID: 24315842 Free article.
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma.
Ahmed S, Ghosh N, Ahn KW, Khanal M, Litovich C, Mussetti A, Chhabra S, Cairo M, Mei M, William B, Nathan S, Bejanyan N, Olsson RF, Dahi PB, van der Poel M, Steinberg A, Kanakry J, Cerny J, Farooq U, Seo S, Kharfan-Dabaja MA, Sureda A, Fenske TS, Hamadani M. Ahmed S, et al. Br J Haematol. 2020 Aug;190(4):573-582. doi: 10.1111/bjh.16664. Epub 2020 Apr 21. Br J Haematol. 2020. PMID: 32314807 Free PMC article.
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.
Dvorak CC, Satwani P, Stieglitz E, Cairo MS, Dang H, Pei Q, Gao Y, Wall D, Mazor T, Olshen AB, Parker JS, Kahwash S, Hirsch B, Raimondi S, Patel N, Skeens M, Cooper T, Mehta PA, Grupp SA, Loh ML. Dvorak CC, et al. Pediatr Blood Cancer. 2018 Jul;65(7):e27034. doi: 10.1002/pbc.27034. Epub 2018 Mar 12. Pediatr Blood Cancer. 2018. PMID: 29528181 Free PMC article. Clinical Trial.
Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.
Patel SS, Rybicki L, Pohlman B, Bolwell B, Gerds AT, Hamilton BK, Hanna R, Kalaycio M, Majhail NS, Sobecks R. Patel SS, et al. Hematol Oncol Stem Cell Ther. 2020 Sep;13(3):160-165. doi: 10.1016/j.hemonc.2019.09.002. Epub 2019 Oct 11. Hematol Oncol Stem Cell Ther. 2020. PMID: 31628924 Free article. Clinical Trial.
107 results